These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 21228349)

  • 1. Distinct pathways generate peptides from defective ribosomal products for CD8+ T cell immunosurveillance.
    Dolan BP; Li L; Veltri CA; Ireland CM; Bennink JR; Yewdell JW
    J Immunol; 2011 Feb; 186(4):2065-72. PubMed ID: 21228349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MHC class I antigen presentation of DRiP-derived peptides from a model antigen is not dependent on the AAA ATPase p97.
    Palmer AL; Dolan BP
    PLoS One; 2013; 8(7):e67796. PubMed ID: 23844095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tight linkage between translation and MHC class I peptide ligand generation implies specialized antigen processing for defective ribosomal products.
    Qian SB; Reits E; Neefjes J; Deslich JM; Bennink JR; Yewdell JW
    J Immunol; 2006 Jul; 177(1):227-33. PubMed ID: 16785518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA polymerase II inhibitors dissociate antigenic peptide generation from normal viral protein synthesis: a role for nuclear translation in defective ribosomal product synthesis?
    Dolan BP; Knowlton JJ; David A; Bennink JR; Yewdell JW
    J Immunol; 2010 Dec; 185(11):6728-33. PubMed ID: 21048111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defective ribosomal products are the major source of antigenic peptides endogenously generated from influenza A virus neuraminidase.
    Dolan BP; Li L; Takeda K; Bennink JR; Yewdell JW
    J Immunol; 2010 Feb; 184(3):1419-24. PubMed ID: 20038640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corticosterone impairs MHC class I antigen presentation by dendritic cells via reduction of peptide generation.
    Truckenmiller ME; Princiotta MF; Norbury CC; Bonneau RH
    J Neuroimmunol; 2005 Mar; 160(1-2):48-60. PubMed ID: 15710457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prime-boost with alternating DNA vaccines designed to engage different antigen presentation pathways generates high frequencies of peptide-specific CD8+ T cells.
    Radcliffe JN; Roddick JS; Friedmann PS; Stevenson FK; Thirdborough SM
    J Immunol; 2006 Nov; 177(10):6626-33. PubMed ID: 17082574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Processing of recombinant Listeria monocytogenes proteins for MHC class I presentation follows a dedicated, high-efficiency pathway.
    Wolf BJ; Princiotta MF
    J Immunol; 2013 Mar; 190(6):2501-9. PubMed ID: 23396941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re-examining class-I presentation and the DRiP hypothesis.
    Rock KL; Farfán-Arribas DJ; Colbert JD; Goldberg AL
    Trends Immunol; 2014 Apr; 35(4):144-52. PubMed ID: 24566257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial heat shock proteins promote CD91-dependent class I MHC cross-presentation of chaperoned peptide to CD8+ T cells by cytosolic mechanisms in dendritic cells versus vacuolar mechanisms in macrophages.
    Tobian AA; Canaday DH; Boom WH; Harding CV
    J Immunol; 2004 May; 172(9):5277-86. PubMed ID: 15100266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced priming of multispecific, murine CD8+ T cell responses by DNA vaccines expressing stress protein-binding polytope peptides.
    Schirmbeck R; Fissolo N; Chaplin P; Reimann J
    J Immunol; 2003 Aug; 171(3):1240-6. PubMed ID: 12874211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xenogeneic beta 2-microglobulin substitution affects functional binding of MHC class I molecules by CD8+ T cells.
    Benoit LA; Tan R
    J Immunol; 2007 Sep; 179(6):3588-95. PubMed ID: 17785793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TLR7 triggering with polyuridylic acid promotes cross-presentation in CD8α+ conventional dendritic cells by enhancing antigen preservation and MHC class I antigen permanence on the dendritic cell surface.
    Crespo MI; Zacca ER; Núñez NG; Ranocchia RP; Maccioni M; Maletto BA; Pistoresi-Palencia MC; Morón G
    J Immunol; 2013 Feb; 190(3):948-60. PubMed ID: 23284054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective ribosomal products (DRiPs): a major source of antigenic peptides for MHC class I molecules?
    Yewdell JW; Antón LC; Bennink JR
    J Immunol; 1996 Sep; 157(5):1823-6. PubMed ID: 8757297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compartmentalized MHC class I antigen processing enhances immunosurveillance by circumventing the law of mass action.
    Lev A; Princiotta MF; Zanker D; Takeda K; Gibbs JS; Kumagai C; Waffarn E; Dolan BP; Burgevin A; Van Endert P; Chen W; Bennink JR; Yewdell JW
    Proc Natl Acad Sci U S A; 2010 Apr; 107(15):6964-9. PubMed ID: 20351281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the role of bleomycin hydrolase in antigen presentation and the generation of CD8 T cell responses.
    Towne CF; York IA; Watkin LB; Lazo JS; Rock KL
    J Immunol; 2007 Jun; 178(11):6923-30. PubMed ID: 17513741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using intein catalysis to probe the origin of major histocompatibility complex class I-presented peptides.
    Farfán-Arribas DJ; Stern LJ; Rock KL
    Proc Natl Acad Sci U S A; 2012 Oct; 109(42):16998-7003. PubMed ID: 23027972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycobacterium tuberculosis heat shock fusion protein enhances class I MHC cross-processing and -presentation by B lymphocytes.
    Tobian AA; Harding CV; Canaday DH
    J Immunol; 2005 May; 174(9):5209-14. PubMed ID: 15843516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MHC class I antigen processing distinguishes endogenous antigens based on their translation from cellular vs. viral mRNA.
    Dolan BP; Sharma AA; Gibbs JS; Cunningham TJ; Bennink JR; Yewdell JW
    Proc Natl Acad Sci U S A; 2012 May; 109(18):7025-30. PubMed ID: 22509014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leishmania antigens are presented to CD8+ T cells by a transporter associated with antigen processing-independent pathway in vitro and in vivo.
    Bertholet S; Goldszmid R; Morrot A; Debrabant A; Afrin F; Collazo-Custodio C; Houde M; Desjardins M; Sher A; Sacks D
    J Immunol; 2006 Sep; 177(6):3525-33. PubMed ID: 16951311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.